Pfizer Inc.
SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS

Last updated:

Abstract:

Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.

Status:
Application
Type:

Utility

Filling date:

16 Jan 2020

Issue date:

14 May 2020